In 2019, private enterprises dedicated CHF 15.5 billion in Switzerland to their research and development (R&D) activities, i.e. an increase of 9% compared with the revised figure for 2017. With CHF 5.2 billion, the pharmaceutical sector invested the most in R&D in Switzerland. Research activities in private enterprises were carried out by almost 58 700 persons, a quarter of whom were women. These are the main results of a study carried out by the Federal Statistical Office (FSO) in partnership with economiesuisse.
You can find further information such as tables and graphs in the press releases in German, French and Italian. The English version only contains the lead of the press release.